Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9248985 | 0.81 | ALDH1A1 (0.33) | ALDH1A1TDP1TRPA1 | |
| Acetic Acid SCHEMBL8521559 | 0.80 | FFAR3 (0.44) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| Acetic Acid SCHEMBL9779003 | 0.80 | FFAR3 (0.44) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL1604126 | 0.79 | ALDH1A1 (0.38) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL9747466 | 0.78 | ALDH1A1 (0.46) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL176385 | 0.76 | ALDH1A1 (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL461282 | 0.75 | ALDH1A1 (0.32) | ALDH1A1LMNA | |
| Methylamine SCHEMBL28402560 | 0.75 | TSHR (0.35) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL6394238 | 0.74 | ALDH1A1 (0.33) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL11025729 | 0.73 | CYP2D6 (0.41) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115251518-A | Outsole and method for producing an outsole | 耐克创新有限合伙公司 | 2022-11-01 | — | — | CN | disclosed |
| US-20170096446-A1 | Extended Triterpene Derivatives | MYREXIS, INC. (US) | 2017-04-06 | — | — | US | disclosed |
| US-9505800-B2 | Extended triterpene derivatives | MYREXIS, INC. (US) | 2016-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096446-A1 | Extended Triterpene Derivatives | BET1, PGGT1B, TMPO | TSHR 4604/4885CYP2D6 417/4885CYP2C19 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.